Phase III study of panobinostat with bortezomib and dexamethasone in patients with relapsed multiple myeloma (PANORAMA 1).
Jesùs F. San-Miguel
Consultant or Advisory Role - Novartis; Novartis
Honoraria - Novartis; Novartis
Philippe Moreau
Honoraria - Novartis
Sung-Soo Yoon
No relevant relationships to disclose
Meletios A. Dimopoulos
Consultant or Advisory Role - Novartis; Ortho Biotech
Honoraria - Novartis; Ortho Biotech
Vânia Tietsche de Moraes Hungria
No relevant relationships to disclose
Wieslaw W. Jedrzejczak
Honoraria - Novartis
Research Funding - Novartis
Other Remuneration - Novartis
Ashraf el Ghandour
No relevant relationships to disclose
Paolo Corradini
Honoraria - Celgene; Genzyme; Novartis
Andreas Günther
Research Funding - Novartis
Expert Testimony - Novartis
Meral Beksac
Honoraria - Janssen-Cilag
Kwee Yong
Honoraria - Celgene; Janssen-Cilag
Jae Hoon Lee
No relevant relationships to disclose
Sagar Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Jian Hou
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Hermann Einsele
Consultant or Advisory Role - Novartis
Monika M Wroclawska-Swacha
Employment or Leadership Position - Novartis
Hans-Jochen Weber
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Priscille M. Bourquelot
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Paul Gerard Guy Richardson
Consultant or Advisory Role - Celgene; Johnson & Johnson; Millennium; Novartis